Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Accounts Payables (2019 - 2023)

Historic Accounts Payables for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $9.0 million.

  • ADC Therapeutics' Accounts Payables fell 2268.54% to $9.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $9.0 million, marking a year-over-year decrease of 2268.54%. This contributed to the annual value of $12.4 million for FY2022, which is 10214337.75% up from last year.
  • As of Q3 2023, ADC Therapeutics' Accounts Payables stood at $9.0 million, which was down 2268.54% from $11.7 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Accounts Payables registered a high of $16.5 million during Q1 2022, and its lowest value of $3329.0 during Q4 2019.
  • Over the past 5 years, ADC Therapeutics' median Accounts Payables value was $11.5 million (recorded in 2021), while the average stood at $8.6 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first skyrocketed by 21515673.09% in 2021, then crashed by 4715.86% in 2023.
  • ADC Therapeutics' Accounts Payables (Quarter) stood at $3329.0 in 2019, then soared by 84.62% to $6146.0 in 2020, then skyrocketed by 96.55% to $12080.0 in 2021, then soared by 102143.38% to $12.4 million in 2022, then dropped by 27.32% to $9.0 million in 2023.
  • Its Accounts Payables was $9.0 million in Q3 2023, compared to $11.7 million in Q2 2023 and $8.7 million in Q1 2023.